These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 1363980

  • 1. Efficacy of levocabastine in conjunctival provocation studies.
    Janssens M.
    Doc Ophthalmol; 1992; 82(4):341-51. PubMed ID: 1363980
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of the new ophthalmic antihistamine, 0.05% levocabastine, in the clinical allergen challenge model of allergic conjunctivitis.
    Abelson MB, George MA, Schaefer K, Smith LM.
    J Allergy Clin Immunol; 1994 Sep; 94(3 Pt 1):458-64. PubMed ID: 7916020
    [Abstract] [Full Text] [Related]

  • 3. Comparative efficacy of olopatadine 0.1% ophthalmic solution versus levocabastine 0.05% ophthalmic suspension using the conjunctival allergen challenge model.
    Abelson MB, Greiner JV.
    Curr Med Res Opin; 2004 Dec; 20(12):1953-8. PubMed ID: 15701212
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of 0.05% levocabastine versus 4% sodium cromolyn in the allergen challenge model.
    Abelson MB, George MA, Smith LM.
    Ophthalmology; 1995 Feb; 102(2):310-6. PubMed ID: 7862419
    [Abstract] [Full Text] [Related]

  • 5. Clinical evaluation of twice-daily emedastine 0.05% eye drops (Emadine eye drops) versus levocabastine 0.05% eye drops in patients with allergic conjunctivitis.
    Verin P, Easty DL, Secchi A, Ciprandi G, Partouche P, Nemeth-Wasmer G, Brancato R, Harrisberg CJ, Estivin-Ebrardt C, Coster DJ, Apel AJ, Coroneo MT, Knorr M, Carmichael TR, Kent-Smith BT, Abrantes P, Leonardi A, Cerqueti PM, Modorati G, Martinez M.
    Am J Ophthalmol; 2001 Jun; 131(6):691-8. PubMed ID: 11384563
    [Abstract] [Full Text] [Related]

  • 6. Emedastine ophthalmic solution 0.05% versus levocabastine ophthalmic suspension 0.05% in the treatment of allergic conjunctivitis using the conjunctival allergen challenge model.
    Netland PA, Leahy C, Krenzer KL.
    Am J Ophthalmol; 2000 Dec; 130(6):717-23. PubMed ID: 11124289
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of antihistamine eye drops on the conjunctival provocation test with Japanese cedar pollen allergen.
    Dake Y, Enomoto T, Cheng L, Enomoto K, Shibano A, Ikeda H, Yoda S, Yajin S, Sakota T, Yamanishi E.
    Allergol Int; 2006 Dec; 55(4):373-8. PubMed ID: 17130679
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy of levocabastine hydrochloride ophthalmic suspension in the conjunctival allergen challenge test in Japanese subjects with seasonal allergic conjunctivitis.
    Takamura E, Nomura K, Fujishima H, Fukagawa K, Satake Y, Fukada Y, Sawa M, Uchida E.
    Allergol Int; 2006 Jun; 55(2):157-65. PubMed ID: 17075252
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Topical levocabastine protects better than sodium cromoglycate and placebo in conjunctival provocation tests.
    Rimås M, Kjellman NI, Blychert LO, Björkstén B.
    Allergy; 1990 Jan; 45(1):18-21. PubMed ID: 1968726
    [Abstract] [Full Text] [Related]

  • 16. Double-blind comparison of levocabastine eye drops with sodium cromoglycate and placebo in the treatment of seasonal allergic conjunctivitis.
    Azevedo M, Castel-Branco MG, Oliveira JF, Ramos E, Delgado L, Almeida J.
    Clin Exp Allergy; 1991 Nov; 21(6):689-94. PubMed ID: 1685691
    [Abstract] [Full Text] [Related]

  • 17. Nedocromil sodium and levocabastine reduce the symptoms of conjunctival allergen challenge by different mechanisms.
    Ahluwalia P, Anderson DF, Wilson SJ, McGill JI, Church MK.
    J Allergy Clin Immunol; 2001 Sep; 108(3):449-54. PubMed ID: 11544467
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.